Clearance of persistent hepatitis B virus infection in chinese bone marrow transplant recipients whose donors were anti-hepatitis B core- and anti-hepatitis B surface antibody-positive

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1585-1591

  Lau, George K K ^a   Liang, Raymond ^b   Lee, Cheuk Kwong ^b   Yuen, Siu Tsan ^b   Hou, Jinlin ^b   Lim, Wei Ling ^b   Williams, Roger ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FAMCICLOVIR; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY TITER; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMORBIDITY; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS B; HUMAN; INFECTION RESISTANCE; MALE; MYELOMA; NONHODGKIN LYMPHOMA; ORGAN DONOR; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; VIRUS EXCRETION;

ADOLESCENT; ADULT; BONE MARROW; BONE MARROW TRANSPLANTATION; CHILD; CHINA; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HONG KONG; HUMANS; LIVER DISEASES; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031767805     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314497     Document Type: Article

References (17)

1. Lok ASF. Treatment of chronic hepatitis B. J Viral Hepat 1994;1:105-24.
2. Rehermann B, Lau D, Hoofnagle JH, Chisari F. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1996;97:1655-65.
3. Lok ASF, Liang RH, Chung H. Recovery from hepatitis B [letter]). Ann Intern Med 1992;116:957.
4. Ilan Y, Nagler A, Adler R, Tur-Kaspa R, Slavin S, Shouval D. Ablation of persistent hepatitis B by BMT from a hepatitis B immune donor. Gastroenterology 1993;104:1818-21.
5. Chen PM, Fan S, Liu CJ, et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 1990;49:708-13.
6. Reed EC, Myerson D, Corey HT, Meyers JD. Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen. Blood 1991:77:195-200.
7. Lau GKK, Lok ASF, Liang R, et al. Clearance of HBsAg after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 1997;25:1497-501.
8. Lau GKK, Liang R, Lee CK, Lim WL. Is vaccination of donor adequate for clearance of hepatitis B virus after bone marrow transplantation [letter]? Lancet 1997;349:1626-7.
9. Brugger SA, Oesterrcicher C, Hofmann H, Kaths P, Greninix HT, Muller C. Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunized donor. Lancet 1997;349:996-7.
10. Lau GKK, Carmen WF, Wang BE. Immunological approaches to the break- down of hepatitis B viral persistence. Chin Med J (Engl) 1998;111:560-4.
11. Lau GKK, Liang R, Wu PC, Lee CK, Lim WL, Au WY. Use of famciclovir to prevent HBV reactivation in HBsAg positive recipients after allogeneic bone marrow transplantation. J Hepatol 1998;28:359-68.
12. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venoocclusive disease of the liver after BMT: diagnosis, incidence and predisposing factors. Hepatology 1984;4:116-22.
13. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18;295-304.
14. Urdea MS, Kolberg J, Warner BD, et al., A novel method for the rapid detection of hepatitis B virus in human serum samples without blotting or radioactivity. In: Van Dyke K, ed. Luminescence immunoassay and molecular applications. Boston: CRC Press, 1990:275-92.
15. Lau JYN, Davis GL, Kniffens J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-4.
16. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
17. Wu PC, Fang JWS, Lai CL, Lau SKH, Lo CK. Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection. Am J Clin Pathol 1996;105:87-95.